Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Diagnostic Value and Safety of Endobronchial Ultrasound-guided Transbronchial Mediastinal Cryobiopsy Versus Transbronchial Needle Aspiration in the Diagnosis of Lymphoma: a Randomized Controlled Trial [NA]
This clinical trial update evaluates diagnostic methods—endobronchial ultrasound-guided transbronchial mediastinal cryobiopsy versus transbr…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Impact of a Sensory Rehabilitation Program on Olfactory-gustatory Alterations in Patients Treated With Chemotherapy for Haematological Cancer [NA]
Clinical trial update indicating termination of a study assessing a sensory rehabilitation program for olfactory and gustatory alterations i…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: First-in-human Dose Escalation and Expansion Study With the SIRPα-directed Monoclonal Antibody BYON4228 [Phase 1]
Phase 1 first-in-human dose escalation and expansion study of BYON4228, a SIRPα-directed monoclonal antibody, in lymphoma.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma [Phase 1, Phase 2]
This clinical trial update describes HX111 testing in patients with advanced solid tumors and lymphoma, currently in Phase 1/2 and not yet r…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial [Phase 3]
Phase 3 clinical trial evaluating geriatric evaluation and survivorship health education for older cancer survivors (GEM-S) is currently rec…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Study Evaluating Safety Pharmacokinetics and Pharmacodynamics of AUR112 in Patients With Relapsed Advanced Lymphoma [Phase 1]
Phase 1 study evaluating safety, pharmacokinetics, and pharmacodynamics of AUR112 in patients with relapsed advanced lymphoma is currently r…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Phase II Study of Loncastuximab Tesirine as Consolidation Strategy in Patients With LBCL in PR After CAR T-cell Therapy [Phase 2]
Phase II trial evaluating loncastuximab tesirine as a consolidation therapy for patients with large B-cell lymphoma who achieved partial res…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma [Phase 1, Phase 2]
This update covers the Phase 1/2 study of the investigational agent NUC-7738 in patients with advanced solid tumors and lymphoma, focusing o…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel [EARLY_Phase 1]
An early Phase 1 trial is evaluating intrathecal dexamethasone and simvastatin to prevent neurotoxicity after axicabtagene ciloleucel therap…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer [NA]
This clinical trial update describes an intervention to help patients and caregivers manage stress and improve communication about cancer, w…
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Clinical Cohort of Lymphoma Patients in Malawi
UNC Lineberger Comprehensive Cancer Center is recruiting a clinical cohort of lymphoma patients in Malawi (NCT02835911).
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating ZG005 in combination with Gecacitinib in patients with relapsed or refractory lymphoma. The s…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies [Phase 1]
Phase 1 trial update evaluating allogeneic CD19-CAR-T cells for relapsed/refractory B-cell hematologic malignancies, with recruitment not ye…
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial from Chinese PLA General Hospital is evaluating eliglustat in combination with a CD30-targeted immunotherap…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating mosunetuzumab alone or in combination with zanubrutinib in people with follicular lymphoma and other …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors [EARLY_Phase 1]
This document provides an update on an early-phase clinical trial evaluating the safety and efficacy of GT719 Universal Cell Injection in ad…
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies [NA]
This clinical trial compares reduced-dose apixaban and rivaroxaban against low-molecular-weight heparin for venous thromboembolism managemen…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
This update reports on a clinical trial of brentuximab vedotin in adults with CD30-positive lymphoma and indicates the study is currently ac…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: xDRIVE for Florida-based Cancer Patients [NA]
A Florida-based clinical trial for a cancer therapy named xDRIVE is currently recruiting, sponsored by First Ascent Biomedical Inc.
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Bone Marrow Grafting for Leukemia and Lymphoma
Stanford University is conducting a bone marrow grafting trial for leukemia and lymphoma, with enrollment by invitation.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors [Phase 1]
Phase I clinical trial update evaluating dose, pharmacokinetics, and safety of Lutetium-177-edotreotide therapy in pediatric participants wi…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Shanghai Lymphoma Clinical Cohort
This clinical trial update reports a Shanghai-based lymphoma cohort study sponsored by Ruijin Hospital that is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Precision Physical Exercise for Personalized Onco-Hematology. [NA]
An update on a clinical trial evaluating precision physical exercise for personalized management in onco-hematology, spanning hematologic ca…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Application of Telemedicine to the Management of Aggressive Lymphomas [NA]
This update reports on a completed clinical trial evaluating the use of telemedicine in managing patients with aggressive lymphomas.
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma [Phase 1]
Phase 1 clinical trial update of anti-CD19 CAR-T cells with an inducible caspase-9 safety switch for B-cell lymphoma, currently active but n…